Terms: = Endocrine gland cancer AND CASP8, ALPS2B, 841, ENSG00000064012, MGC78473, CAP4, MACH, MCH5, FLICE AND Treatment
70 results:
1. Systematic pharmacology-based strategy to explore the mechanism of Semen Strychni for treatment of papillary thyroid carcinoma.
Mao J; Tang L; Fang L; Tian C; Zhu Z; Li Y
Sci Rep; 2023 Oct; 13(1):18492. PubMed ID: 37898675
[TBL] [Abstract] [Full Text] [Related]
2. Exploration of pyroptosis-associated prognostic gene signature and lncRNA regulatory network in ovarian cancer.
Zhang B; Li Z; Wang K; Duan M; Yin Y; Zhan Q; Wang F; An R
Comput Biol Med; 2023 Sep; 164():107343. PubMed ID: 37566932
[TBL] [Abstract] [Full Text] [Related]
3. Herniarin-loaded solid lipid nanoparticles: promising molecular mechanism and therapeutic potential against pancreatic cancer line.
Delkhah AMD; Karimi E; Farivar S
Mol Biol Rep; 2023 Aug; 50(8):6469-6479. PubMed ID: 37326747
[TBL] [Abstract] [Full Text] [Related]
4. Evaluation of the anticancer effect of telomerase inhibitor BIBR1532 in anaplastic thyroid cancer in terms of apoptosis, migration and cell cycle.
Turkmen E; Sogutlu F; Erdogan M; Biray Avci C
Med Oncol; 2023 Jun; 40(7):196. PubMed ID: 37284891
[TBL] [Abstract] [Full Text] [Related]
5. Value of clinical features combined with multimodal ultrasound in predicting lymph node metastasis in cervical central area of papillary thyroid carcinoma.
Xue J; Li S; Qu N; Wang G; Chen H; Wu Z; Cao X
J Clin Ultrasound; 2023 Jun; 51(5):908-918. PubMed ID: 37058552
[TBL] [Abstract] [Full Text] [Related]
6. Breast cancer risk among thyroid cancer survivors and the role of I-131 treatment.
Tran TV; Rubino C; Allodji R; Andruccioli M; Bardet S; Diallo I; Dottorini M; Garsi J; Hall P; Henry-Amar M; Lamart S; Le Thai F; Lönn S; Ricard M; Schvartz C; Schlumberger M; Journy N; de Vathaire F
Br J Cancer; 2022 Dec; 127(12):2118-2124. PubMed ID: 36224404
[TBL] [Abstract] [Full Text] [Related]
7. RPS27 selectively regulates the expression and alternative splicing of inflammatory and immune response genes in thyroid cancer cells.
Wan J; Lv J; Wang C; Zhang L
Adv Clin Exp Med; 2022 Aug; 31(8):889-901. PubMed ID: 35546566
[TBL] [Abstract] [Full Text] [Related]
8. A prognostic model of patients with ovarian mucinous adenocarcinoma: a population-based analysis.
Yang L; Yu J; Zhang S; Shan Y; Li Y; Xu L; Zhang J; Zhang J
J Ovarian Res; 2022 Feb; 15(1):26. PubMed ID: 35168642
[TBL] [Abstract] [Full Text] [Related]
9. Estimated tumor blood flow as a predictive imaging indicator of therapeutic response in pancreatic ductal adenocarcinoma: use of three-phase contrast-enhanced computed tomography.
Maehira H; Tsuji Y; Iida H; Mori H; Nitta N; Maekawa T; Kaida S; Miyake T; Tani M
Int J Clin Oncol; 2022 Feb; 27(2):373-382. PubMed ID: 34783936
[TBL] [Abstract] [Full Text] [Related]
10. Pharmacoethnicity of FOLFIRINOX versus gemcitabine plus nab-paclitaxel in metastatic pancreatic cancer: a systematic review and meta-analysis.
Lee YS; Lee JC; Kim JH; Kim J; Hwang JH
Sci Rep; 2021 Oct; 11(1):20152. PubMed ID: 34635731
[TBL] [Abstract] [Full Text] [Related]
11. Cost-effectiveness analysis of FOLFIRINOX vs gemcitabine with nab-paclitaxel as adjuvant treatment for resected pancreatic cancer in the United States based on PRODIGE-24 and APACT trials.
Kharat AA; Nelson R; Au T; Biskupiak J
J Manag Care Spec Pharm; 2021 Oct; 27(10):1367-1375. PubMed ID: 34595948
[No Abstract] [Full Text] [Related]
12. Reduction of overtreatment without reduction of overdiagnosis in patients with differentiated thyroid cancer: mission impossible.
Oblak T; Perhavec A; Hocevar M; Peric B
Langenbecks Arch Surg; 2021 Sep; 406(6):2011-2017. PubMed ID: 34097134
[TBL] [Abstract] [Full Text] [Related]
13. Comparative analysis of pituitary adenoma with and without apoplexy in pediatric and adolescent patients: a clinical series of 80 patients.
Wang R; Wang Z; Song Y; Li L; Han X; Han S
Neurosurg Rev; 2022 Feb; 45(1):491-498. PubMed ID: 33914243
[TBL] [Abstract] [Full Text] [Related]
14. Gemcitabine plus nab-paclitaxel versus FOLFIRINOX for unresected pancreatic cancer: Comparative effectiveness and evaluation of tumor growth in Veterans.
Sigel K; Zhou M; Park YA; Mutetwa T; Nadkarni G; Yeh C; Polak P; Sigel C; Conroy T; Juzyna B; Ychou M; Fojo T; Wisnivesky JP; Bates SE
Semin Oncol; 2021 Feb; 48(1):69-75. PubMed ID: 33714591
[TBL] [Abstract] [Full Text] [Related]
15. Survival impact of extended cycles of second-line chemotherapy in platinum-sensitive relapsed ovarian cancer patients with residual tumor after six cycles.
Kim SI; Hwang WY; Lee M; Kim HS; Kim K; Chung HH; No JH; Kim JW; Kim YB; Park NH; Song YS; Suh DH
BMC Cancer; 2020 Dec; 20(1):1199. PubMed ID: 33287758
[TBL] [Abstract] [Full Text] [Related]
16. Possible candidate population for neoadjuvant chemotherapy in women with advanced ovarian cancer.
Matsuo K; Matsuzaki S; Nusbaum DJ; Maoz A; Oda K; Klar M; Roman LD; Sood AK
Gynecol Oncol; 2021 Jan; 160(1):32-39. PubMed ID: 33196436
[TBL] [Abstract] [Full Text] [Related]
17. Iodine Nutrition and the Prevalence Status of Thyroid Nodules in the Population: a Cross-sectional Survey in Heilongjiang Province, China.
Tian C; Bu Y; Ji C; Shi M; Zhang L; Kong D; Dong X; Liu Y
Biol Trace Elem Res; 2021 Sep; 199(9):3181-3189. PubMed ID: 33123864
[TBL] [Abstract] [Full Text] [Related]
18. Postoperative Day 1 Morning Cortisol Value as a Biomarker to Predict Long-term Remission of Cushing Disease.
Wang F; Catalino MP; Bi WL; Dunn IF; Smith TR; Guo Y; Hordejuk D; Kaiser UB; Laws ER; Min L
J Clin Endocrinol Metab; 2021 Jan; 106(1):e94-e102. PubMed ID: 33108450
[TBL] [Abstract] [Full Text] [Related]
19. Applying a radiomics-based strategy to preoperatively predict lymph node metastasis in the resectable pancreatic ductal adenocarcinoma.
Liu P; Gu Q; Hu X; Tan X; Liu J; Xie A; Huang F
J Xray Sci Technol; 2020; 28(6):1113-1121. PubMed ID: 33074215
[TBL] [Abstract] [Full Text] [Related]
20. Prognostic role of thrombocytosis in recurrent ovarian cancer: a pooled analysis of the AGO Study Group.
Canzler U; Lück HJ; Neuser P; Sehouli J; Burges A; Harter P; Schmalfeldt B; Aminossadati B; Mahner S; Kommoss S; Wimberger P; Pfisterer J; de Gregorio N; Hasenburg A; Gropp-Meier M; El-Balat A; Jackisch C; du Bois A; Meier W; Wagner U
Arch Gynecol Obstet; 2020 May; 301(5):1267-1274. PubMed ID: 32277253
[TBL] [Abstract] [Full Text] [Related]
[Next]
